Additionally, a correlation has been demonstrated between low RYR2 expression and unfavorable prognoses in patients diagnosed with thyroid and breast cancer patients (32, 33); however, mutations at these loci remain underexplored in OV. This evidence concerns the gene RYR2 and thyroid gland disorder.